Objective: Antioxidant therapy has shown some promise in critical care medicine in which glutathione depletion and heart failure are often seen in critically ill patients. This study was designed to examine the impact of glutathione depletion and the free radical scavenger, metallothionein (MT), on cardiac function.
O xidant balance is essential to the maintenance of physiologic cardiac function (1, 2) . The antioxidant reserve often becomes inadequate in critically ill patients, leading to oxidative stress and myocardial dysfunction (1, (3) (4) (5) . Several thiol-rich enzymatic or nonenzymatic components, such as glutathione (GSH) and metallothionein (MT), have been shown to preserve cardiac func-tion by scavenging reactive oxygen species (ROS) under ischemic and diabetic injury (6 -9) , which is consistent with the beneficial response of antioxidant therapy in critical care medicine (3) . GSH defends against oxidative stress through the glutathione redox cycle by accepting peroxides and peroxidederived ROS or serving as a cofactor for antioxidant enzymes (10, 11) . Depletion or loss of GSH has been commonly found in critically ill patients (12) , contributing to oxidative injury (8, 13) . Nonetheless, the role of GSH loss in heart failure in critically ill patients is still unknown. Given the cardiac benefit of MT, a potent thio-rich scavenger of ROS especially hydroxyl radicals (6 -9) , this study was designed to examine the effect of GSH depletion on myocardial function and ultrastructure in mice with cardiac-specific overexpression of MT. Buthionine sulfoximine (BSO), a selective inhibitor of ␥-glutamylcysteine synthetase and the de novo GSH synthesis (14) , was used to deplete GSH to elicit an irreversible oxidative dam-age (13) . Echocardiographic, cardiomyocyte contractile, ultrastructural, and intracellular Ca 2ϩ properties were evaluated. Doxorubicin, a potent antineoplastic agent prescribed for cancer treatment, was used as a positive control for oxidative cardiomyopathy (15) . MT was reported to reverse doxorubicin-induced cardiac toxicity, including functional and morphologic integrity (6, 7) , although little is known about cardiomyocyte contractile and intracellular Ca 2ϩ properties. Oxidative stress, protein damage, mitochondrial function, and apoptosis were examined using reduced-to-oxidized GSH ratio, carbonyl formation, mitochondrial aconitase, and caspase-3 activity, respectively. To explore the mechanism of action involved in intracellular Ca 2ϩ homeostasis and apoptosis in response to BSO and MT exposure, expression of the Ca 2ϩ regulating proteins sarco (endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA), phospholamban, calreticulin, myosin heavy chain (MHC), Kv 1.2 channel, anti-apoptotic (apoptosis repressor with caspase recruitment domain [ARC] and Bcl-2), and pro-apoptotic (p53, Bax, NFB, and glycogen synthase kinase-3␤ [GSK-3␤]) proteins also was monitored.
MATERIALS AND METHODS

Experimental Animals, Treatment with BSO, and Doxorubicin
The experimental protocols were approved by our institutional Animal Use and Care Committee. Five-month-old, male transgenic mice with a ten-fold MT protein overexpression driven by the cardiac-specific mouse ␣-MHC promoter (6) and wild-type Friend virus B (FVB) mice were maintained on a 12/12-light/dark cycle with lab chow and water ad libitum. A cohort of FVB and MT mice was given BSO (30 mmol/L) in drinking water for 2 wks (13) . Another cohort of FVB and MT mice was injected with doxorubicin hydrochloride (20 mg/kg body weight, intraperitoneally) 5 days before experimentation (6) . Systolic blood pressure was measured with a semiautomated, amplified tail cuff device.
Echocardiographic Assessment. Animals were anesthetized by using 2.5% avertin (10 L/g body weight). Two-dimensional (2-D) guided M-mode echocardiography was performed using a Phillips echocardiography system (Sonos 5500) equipped with a 15-6 MHz linear transducer. The heart was first imaged in the 2-D mode in parasternal short-axis views, which were used to position the Mmode cursor perpendicular to ventricular septum and left ventricular (LV) posterior wall and to subsequently obtain M-mode images. Anterior and posterior wall thickness and diastolic and systolic LV dimensions were recorded from M-mode images using averaged measurements from 3 cardiac cycles with the leading edge-to-leading-edge convention adopted by the American Society of Echocardiography (16) . Fractional shortening was calculated from end-diastolic diameter (EDD) and end-systolic diameter (ESD). Heart rates were averaged over 10 cardiac cycles.
Cardiomyocyte Isolation. After ketamine/ xylazine sedation, hearts were removed and perfused with Krebs-Henseleit bicarbonate (KHB) buffer containing (in mmol/L): 118 NaCl, 4.7 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , 10 HEPES, and 11.1 glucose. Hearts were digested with collagenase D for 20 mins. Left ventricles were removed and minced before being filtered (17) . The percentage of the rod-shaped viable cardiomyocytes was ϳ70%, as determined using a hemacytometer. Neither BSO nor MT overtly affected the cardiomyocyte yield.
Cardiomyocyte Contractile Function. Mechanical properties of myocytes were assessed using an IonOptix soft-edge system (IonOptix, Milton, MA) (17) . Myocytes were placed in a chamber mounted on the stage of an Olympus IX-70 microscope and superfused (ϳ2 mL/min at 25°C) with a KHB buffer containing 1 mmol/L CaCl 2 . Myocytes were field stimulated at 0.5 Hz unless otherwise stated. Cell shortening and relengthening were assessed, including peak shortening (PS) -peak contractility, time-to-PS (TPS) -contraction duration, time-to-90% relengthening (TR 90 )relaxation duration and maximal velocities of shortening/relengthening (ϮdL/dt) -maximal pressure development and decline.
Intracellular Ca 2ϩ and SR Ca 2ϩ . Intracellular Ca 2ϩ was evaluated with a dual-excitation, single-emission photomultiplier system (IonOptix) in myocytes loaded with fura-2 (0.5 mol/L) (17) . Myocytes were exposed to light emitted by a 75W halogen lamp through a 360-nm or 380-nm filter while being stimulated to contract at 0.5 Hz. Fluorescence emissions were detected between 480 and 520 nm and qualitative changes in intracellular Ca 2ϩ were inferred from the ratio of fura-fluorescence intensity (FFI) at 360/380 nm. Fluorescence decay was measured as an indicator for intracellular Ca 2ϩ clearing. SR Ca 2ϩ release was assessed by rapid puffing of caffeine (10 mmol/L) in fura-2-loaded myocytes. Multiple applications of caffeine were given at 5-min intervals to ensure a steady state.
Reduced and Oxidized Glutathione (GSH and Glutathione Disulfide [GSSG] ). Tissue samples were homogenized and centrifuged. Supernatant fractions were collected for GSH and GSSG assay. Half of each sample was used for GSH determination and the other half for GSSG. Samples (100 L) were incubated at room temperature with 2 L 4-vinyl pyridine for 1 hr to conjugate GSH for determination of GSSG. The GSSG was then subtracted from the total glutathione to determine the GSH levels (18) .
ROS Detection. Highly reactive oxygen species (hROS) were assessed with 2-[6-(4Јhydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (HPF) and 2-[6-(4Ј-amino)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (APF) (Molecular Probes, Eugene, OR). APF is highly specific for hydroxyl radical and hypochlorite with little reactivity toward superoxide, alkylperoxyl radical, oxygen radical, and nitric oxide. On the other hand, HPF is useful for hydroxyl radical. Total ROS was determined by 2Ј,7Ј-dichlorodihydrofluorescein (DCF). Isolated cardiomyocytes were loaded with APF, HPF, or DCF (5 mol/L) at 37°C for 1 hr, and fluorescent intensity was measured by using a fluorescent microplate reader at an excitation wavelength of 488 nm and an emission wavelength of 515 nm (9, 19) .
Protein Carbonyl. Protein was precipitated by adding an equal volume of 20% trichloroacetic acid (TCA) and centrifuged for 1 min. The sample resuspended in 10 mmol/L 2,4dinitrophenylhydrazine solution for 15-30 mins at room temperature before 20% TCA was added and samples were centrifuged for 3 mins. The precipitate was resuspended in 6 mol/L guanidine solution. The maximum absorbance (360 -390 nm) was read against appropriate blanks (2 mol/L HCl) and carbonyl content was normalized to respective protein content (17) .
Lipid Peroxidation End Product Malondialdehyde (MDA). Samples were treated with butylated hydroxytoluene and were heated to 90°C for 45 mins. The mixture was centrifuged and samples were eluted with a high performance liquid chromatography system fitted with a Shimadzu SIL-10A autoinjector and a Waters Symmetry column (C18, 5.0 m particle size, 4.6 mm ϫ 250 mm) (Waters, Milford, MA). The MDA peak of interest was eluted at 8 mins and detected by using a Waters 474 scanning fluorescence detector at 532 nm excitation and 553 nm emission (18) .
Caspase-3 Assay. Cardiomyocytes were lysed in an ice-cold cell lysis buffer before incubating with reaction buffer and caspase-3 colorimetric substrate (Ac-DEVD-pNA) at 37°C for 1 hr, during which time the caspase in the sample was allowed to cleave the chromophore p-NA from the substrate molecule. The samples were then read with a microplate reader at 405 nm. Caspase-3 activity was expressed as picomoles of pNA released per microgram of protein per minute (20) .
Aconitase Activity. Mitochondrial fractions from heart homogenate were resuspended in sodium citrate and aconitase activity assay was performed using an Aconitase-340 assay kit from OxisResearch (Portland, OR) to measure nicotinamide adenine dinucleotide phosphate formation, a product of the oxidation of isocitrate to ␣-ketoglutarate (21) . Mitochondrial samples (50 l) were incubated in a 96-well plate with 50 L trisodium citrate (substrate), 50 l isocitrate dehydrogenase (enzyme), and 50 L nicotinamide adenine dinucleotide phosphate for 15 mins at 37°C. The absorbance was recorded at 340 nm every minute for 5 mins with a SpectraMax 190 Microplate Spectrophotometer.
SERCA Activity. Cells were sonicated and solubilized in a Tris-sucrose homogenization buffer. To determine SERCA-dependent Ca 2ϩ uptake, paired samples were treated with and without 10 mol/L of the SERCA inhibitor thapsigargin for 15 mins. The difference between the two readings was deemed the thapsigargin-sensitive 45 Ca 2ϩ uptake through SERCA. Uptake was initiated by the addition of an aliquot of supernatant from each sample to a solution consisting of (in mmol/L) 100 KCl, 5 NaN 3 , 6 MgCl 2 , 0.15 ethylene glycotetraacetic acid (EGTA), 0.12 CaCl 2 , 30 Tris-HCl pH 7.0, 10 oxalate, 2 adenosine 5Ј-triphosphate (ATP), and 1 Ci 45 CaCl 2 in water bath at 37°C. Aliquots of samples were injected onto glass filters on a suction manifold, washed, and filters were collected for scintillation count. SERCA activity was expressed as cpm/mg protein of the thapsigargin-sensitive 45 Ca 2ϩ uptake (17) .
Electron Microscopy. Mouse abdomens and thoraxes were opened under anesthesia, and the right atria were incised to allow the release of blood. Perfusion fixation was immediately initiated by using a saline washout. Hearts were perfused with 20 mL of warm (37°C), pH 7.6, and PIPES-buffered formaldehyde-glutaraldehyde at ϳ3 mL/minute and followed by 40 mL of the same fixative but chilled to 4°C. Hearts were removed immediately and left ventricular and interventricular septal tissues were collected from a 2-mm ring sliced from the midventricular region. These were further minced to 1 mm 3 . Fixation continued overnight at 4°C in a 10:1 fluid/tissue ratio. This was followed by rinsing in PIPES buffer ϩ 2% sucrose (pH 7.4) and overnight postfixation in PIPES buffered 1% OsO 4 ϩ 2% sucrose and 1.5% K 3 FE(CN) 6 ⅐3H 2 0 at room temperature. Tissue blocks were dehydrated through graded ethanol and propylene oxide, embedded in Epon/Araldite, and cured for 48 hrs at 60°C. Thin sections (silver-gray interference color) were cut on an RMC-MTXL ultramicrotome equipped with a Diatome diamond knife. Sections were collected on naked copper (300-mesh) grids, stained with lead citrate and uranyl acetate (4% in absolute ethanol), and imaged with a Hitachi 7500 transmission electron microscope (22) .
Immunoblotting and MHC Isoform Distribution. Membrane proteins from cardiomyocytes were extracted (17) . Membrane proteins (50 g/lane) were separated on 10 -15% SDSpolyacrylamide gels in a minigel apparatus (Mini-PROTEAN II, Bio-Rad) and transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% milk with a TBS-T solution for 60 mins and then incubated overnight with anti-SERCA2a (1:1000, Affinity BioReagents, Golden, CO), antiphospholamban (1:1000, Abcam, Cambridge, MA), anti-calreticulin (1:1000, Upstate Biotechnology, Lake Placid, NY), anti-Kv 1.2 (1: 1000, Upstate Biotechnology), anti-ARC (1: 1000, Santa Cruz Biotech, Santa Cruz, CA), anti-Bcl-2 (1:800, Santa Cruz Biotech), anti-Bax (1:800, Santa Cruz Biotech), anti-p53 (1: 1000, Oncogene Research Products, Boston, MA), anti-phospho-IB (1:1000, Cell Signaling Technology, Beverly, MA), anti-GSK-3␤ and anti-pGSK-3␤ (Ser9) (1:1000, Cell Signaling Technology) antibodies followed by incubation with horseradish peroxidase-coupled to an anti-mouse secondary antibody. After immunoblotting, the film was scanned and the intensity of immunoblot bands was detected with a Bio-Rad Densitometer. For MHC gel electrophoresis, homogenized heart tissue in a sample buffer (1:30) was heated for 2 mins at 95°C and chilled on ice for 5 mins before being centrifuged. Three microliters of 1:10 diluted supernatant was loaded for electrophoresis as described (21) . After running, gels were fixed for a minimum of 2 hrs in 5% glutaraldehyde before being silverstained and scanned to determine the amount of MHC-␣ and MHC-␤. ␤-actin (1: 5000) was used as the loading control.
Data Analysis
Data were recorded as mean Ϯ standard error of the mean. Statistical significance (p Ͻ .05) was estimated by two-way analysis of variance or Student's t-test with a Dunnett's test as post hoc analysis when required.
RESULTS
General Morphometric and Echocardiographic Characteristics of Mice After BSO Treatment
BSO and MT transgene did not elicit any notable effects on body, organ weights, or blood glucose. The systolic blood pressure was moderately elevated after BSO treatment in both FVB and MT mice. As expected, BSO significantly reduced GSH levels and the GSH/GSSG ratio without altering GSSG levels in hearts, livers, and kidneys, the effect of which was not affected by MT. Interestingly, GSH depletion enhanced protein damage evaluated by carbonyl formation, which was reversed by MT. MT transgene itself did not affect the organ redox state and protein carbonyl levels (Table 1) . Whereas heart rate, EDD, LV mass, and normalized LV mass were comparable among FVB and MT mice with or without BSO treatment, BSO significantly reduced ventricular wall thickness and enlarged ESD, leading to a decreased fraction shortening. MT transgene abrogated BSO-induced myocardial geometric and functional changes without affecting those indices by itself ( Table 2 ). 
Effect of MT and BSO on Cardiomyocyte Mechanical and Fluorescent Properties
The cell phenotype and resting length were comparable among all mouse groups (data not shown). Myocytes from the FVB-BSO group exhibited signifi-cantly depressed PS, reduced ϮdL/dt, and prolonged TR 90 with comparable TPS. This finding was consistent with earlier reports of impaired cardiac contractile function after broad oxidative insults (1, 9, 17, 18, 21, 23) . Similar results on myocyte mechanics were observed in mice treated with doxorubicin, which was used as a positive control because of its known cardiac toxicity (6) . Interestingly, overexpression of MT abrogated both BSO-and doxorubicin-induced decrease in PS and ϮdL/dt as well as prolongation in TR 90 (Fig. 1) . Consistently, BSO depressed electrically stimulated intracellular Ca 2ϩ rise (⌬FFI), SR Ca 2ϩ release, and prolonged intracellular Ca 2ϩ decay without affecting baseline intracellular Ca 2ϩ levels. MT nullified BSO-induced depression of ⌬FFI, reduced SR Ca 2ϩ release, and prolonged intracellular Ca 2ϩ decay. Baseline intracellular Ca 2ϩ levels were decreased in the BSO-treated MT group. The BSO-induced intracellular Ca 2ϩ responses were reminiscent of those induced by doxorubicin. To delineate the possible mechanism(s) responsible for the BSO and MT-elicited changes in intracellular Ca 2ϩ homeostasis, the cardiomyocyte Ca 2ϩ reuptake function was tested by using 45 Ca 2ϩ uptake. The result revealed a declined cardiomyocyte 45 Ca 2ϩ uptake in BSO-and doxorubicin-treated mice, which was restored by MT. MT itself did not alter cardiomyocyte mechanics, intracellular Ca 2ϩ properties, and 45 Ca 2ϩ uptake (Fig. 2) , indicating little innate effect on cardiomyocyte function by MT.
Mouse hearts beat at very high frequencies (Ͼ400/min at 37°C), whereas our baseline stimulus was 0.5 Hz (30 beats/min). To investigate possible derangement of cardiac contractile function at higher frequencies, the stimulating frequency was increased stepwise from 0.1 Hz to 5.0 Hz (300 beats/min) and PS was recorded at steady-state. Cells were initially stimulated to contract at 0.5 Hz for 5 mins to ensure steady-state before commencing the frequency protocol (at 0.1-5.0 Hz). All recordings were normalized to the PS obtained at 0.1 Hz. Myocytes from the FVB-BSO group exhibited significantly exaggerated depression from baseline (0.1 Hz) at both 0.5 Hz and 1.0 Hz without significant change at 3.0 Hz and 5.0 Hz. MT transgene itself did not alter the frequency response pattern, although it completely prevented the BSOinduced depression in PS at 0.5 Hz and 1.0 Hz. Interestingly, doxorubicin failed to duplicate BSO-elicited exaggeration of PS decline in response to increased stimulus frequency (Fig. 1E ).
Effect of MT and BSO on Lipid Peroxidation, ROS, Apoptosis, and Mitochondrial Function
To explore the mechanism(s) of action in MT-elicited protection against GSH depletion-induced cardiac dysfunction, lipid peroxidation, apoptosis, and mitochondrial function, all of which are likely targets of oxidative stress (17, 24 -26) , were examined. BSO significantly increased levels of the lipid peroxidation end product MDA in hearts, livers, and kidneys. Although MT itself did not affect organ MDA levels, it ablated BSO-induced increase in cardiac but not hepatic or renal MDA levels. Assessment of apoptosis using caspase-3 assay also suggested that MT was capable of alleviating BSOtriggered myocyte apoptosis. To explore BSO-induced myocyte injury, cardiac aconitase levels were measured. Aconitase is an iron-sulfur enzyme located in citric acid cycle and mitochondrial aconitase is readily damaged by oxidative stress via removal of an iron from [4Fe-4S] (21) . Our results showed that BSO overtly reduced aconitase activity, the effect of which was rectified by MT. Finally, measurement of total and highly reactive ROS using DCF and APF/HPF depicted significantly increased fluorescent intensity from all three probes. MT effectively antagonized the BSO-elicited ROS generation with little effect itself (Fig. 3 ).
Electron Microscopy
Without BSO treatment, no ultrastructural differences were observed in cardiac samples between the FVB and MT groups (Fig. 4A-B ). BSO treatment in FVB mice induced extensive focal damage in both left ventricular ( Fig. 4C ) and intraventricular septal (data not shown) sections. This was evidenced by cytoarchitectural damage, including mitochondrial swelling and significant disruption of sarcomeres and the arrangement of cardiac contractile filaments. Consistent with the mechanical observations, MT prevented BSO-induced structural damage ( Fig. 4D ) and myocardial tissues from BSO-treated MT mice were ultrastructurally indistinguishable from FVB or MT samples. To examine whether the MTelicited protection on cardiac ultrastructure can be mimicked by exogenously administered antioxidants, the effect of ␣-tocopherol acetate (200 mg/kg body weight administered via gavage for 2 wks) on BSO-induced ultrastructural changes was evaluated (27) . Similar to MT transgene, ␣-tocopherol acetate effectively ameliorated BSO-induced cardiac ultrastructural damage (Fig. 4F ) while exhibiting little ultrastructural effect in the FVB mice (Fig. 4E) , indicating a favorite response of antioxidants against GSH depletion. ␣-tocopherol also improved cardiomyocyte contractile function and intracellular Ca 2ϩ homeostasis in BSOtreated FVB mice (data not shown), consistent with its beneficial role in cardiac oxidant injury, such as sepsis (5, 27) . In addition, reminiscent of its action against BSO as reported previously (6), MT transgene also protected against doxorubicin-induced toxicity on cardiac morphology (Fig. 4G ). Furthermore, BSO significantly reduced mitochondrial density in FVB hearts, the effect of which was nullified by MT ( Fig. 4H ).
Immunoblotting for SERCA2a, Phospholamban, Calreticulin, MHC Isozyme, and Kv 1.2
To understand the mechanism behind changes in intracellular Ca 2ϩ homeostasis in MT-elicited protection against BSO treatment, expression of several key intracellular Ca 2ϩ proteins was evaluated. The immunoblotting data revealed that BSO treatment significantly reduced expression of the Ca 2ϩ re-sequestering protein SERCA2a and the SERCA2a/phospholamban ratio and upregulated the endoplasmic reticulum chaperone calreticulin and MHC-␤ distribution without affecting levels of phospholamban and Kv 1.2 . Although MT itself did not alter protein expression of these Ca 2ϩ regulating proteins, it nullified BSO-induced changes in SERCA2a, SERCA2a/phospholamban ratio, calreticulin, and MHC isozyme redistribution (Fig. 5 ).
Immunoblotting for ARC, p53, Bax, Bcl-2, Phosphorylation of IB, and GSK-3␤
Our data further depicted upregulated proapoptotic proteins Bax and p53, downregulated anti-apoptotic protein Bcl-2, enhanced phosphorylation of the NFB inhibitory subunit IB (which removes its inhibition on NFB), and diminished GSK-3␤ phosphorylation in response to BSO treatment. The expression of total IB and GSK-3␤ was not altered (data not shown). Alterations in these proteins are closely associated with heart failure and oxidative diseases (28, 29) . Although MT itself did not affect expression of these proteins or its phosphorylation, it nullified BSO-induced alteration in Bax, Bcl-2, phosphorylation of IB, and GSK-3␤ with the exception of p53. Levels of the antiapoptotic protein ARC were not affected by BSO or MT (Fig. 6 ).
DISCUSSION
Both tissue GSH depletion and high prevalence of heart failure are commonly seen in critically ill patients (4, 12, 30) , although the link between the two has never been elucidated. Our data revealed for the first time that GSH depletion leads to oxidative stress, protein carbonyl damage, lipid peroxidation, cardiac geometric and contractile defect, and ultrastructural derangement in the hearts, suggesting a potential role of GSH depletion and oxidative stress in the development of heart failure in critically ill patients. The study further indicated that SERCA dysfunction, MHC isozyme switch, enhanced pro-apoptotic, and reduced anti-apoptotic protein abundance may be responsible for the GSH depletion-induced myocardial geometric, contractile, intracellular Ca 2ϩ , and morphologic changes. The loss of ultrastructural integrity in conjunction with reduced mitochondrial density and aconitase activity further depicted that the myopathy may be focal to cardiomyocytes and mitochondria, likely targets for oxidative stress (9, 21, 25) . The fact that the thiol antioxidant MT abrogates BSO-induced functional, ultrastructural, and mitochondrial changes supports the favorite role of antioxidant therapy in critical care medicine (3, 5) .
Our results revealed that GSH depletion resulted in depressed myocardial contraction, prolonged relaxation and intracellular Ca 2ϩ clearing, reduced SR Ca 2ϩ release capacity, and exaggerated PS decline at higher frequencies, consistent with previous reports of compromised myocardial function under oxidant injury and critical illness, such as sepsis and shock (2, 4, 31) . These cardiomyocyte contractile and intracellular Ca 2ϩ defects also were reminiscent of the hallmark cardiomyocyte dysfunction in diabetic and hypertrophic cardiomyopathy, in which oxidative stress plays a key role (17, 23) . The deleterious cardiac effects of GSH depletion is believed to be mediated by ROS, especially hROS independent of H 2 O 2 , NO, and O 2 -(shown by APF/HPF). This is supported by our data that MT nullifies GSH depletion-induced ROS especially hROS accumulation, protein damage, and lipid peroxidation, which are in line with the favorite response of MT on cardiac function and morphology. Several mechanisms may be postulated for the BSO-induced detrimental cardiac defects and MT-offered cardioprotection. First, BSO may impair cardiac function via a ROS-mediated inhibition of intracellular Ca 2ϩ recruitment (32) . ROS has been shown to disrupt myocardial Ca 2ϩ homeostasis through inhibition of L-type Ca 2ϩ currents, SR Ca 2ϩ load, SERCA function, and Na ϩ -Ca 2ϩ exchange (2, 33) . Dysfunction of these Ca 2ϩ regulatory elements contributes to reduced cardiac contractile function (17, 23) consistent with our findings of impaired SERCA expression/function, upregulated calreticulin expression, and compromised intracellular Ca 2ϩ release and decay, as well as reduced fraction shortening, PS, ϮdL/dt and prolonged TR 90 after BSO treatment. Calreticulin, a ROSsensitive endoplasmic reticulum chaperone, is known to sensitize SERCA to oxidative injury (34) . Up-regulated calreticulin expression after BSO treatment may render the free thiol groups in calreticulin and SERCA more sensitive to oxidative protein damage (35) , which is in line with the carbonyl formation data from this study. It is worth mentioning that systolic duration, resting intracellular Ca 2ϩ level, phospholamban and Kv 1.2 channel were not affected by BSO, indicating possible disparity in the sensitivity of cardiac contractile/Ca 2ϩ regulating proteins to GSH depletion-elicited oxidative stress. Interestingly, the GSH depletion-induced depression of SERCA expression/function, up-regulation of calreticulin, myocardial mechanical, and intracellular Ca 2ϩ defects were abrogated by MT in parallel with MT-elicited inhibition on ROS generation, lipid peroxidation, and protein carbonyl formation. These data support the notion that ROS and SERCA function may be essential to MT-elicited protection against BSOinduced cardiac mechanical and intracellular Ca 2ϩ dysfunction. The culprit role of ROS in BSO-induced cardiomyocyte dysfunction was further testified by the ROS inducer doxorubicin-induced contractile and intracellular Ca 2ϩ responses. Second, MHC isozyme switch from ␣to ␤in response to GSH depletion and MT transgene overexpression may contribute to myocardial remodeling (changes in wall thickness and ESD) and myopathic changes in FVB and MT mice. Third, our observation of extensive ultrastructural damage, especially mitochondrial swelling and reduced mitochondrial density after chronic GSH depletion, indicates that mitochondrial integrity plays a role in BSO-induced myocardial dysfunction and MT-offered protection. The morpho-logic changes in mitochondria in response to BSO and MT received further support from mitochondrial aconitase activity and GSK-3␤ phosphorylation, which play integral roles in mitochondrial permeability transition pore (36) . GSH is required to metabolize ROS generated by the mitochondria (32) . Mitochondria have been considered the main targets for ROS insult and may exhibit mitochondrial permeability transition leading to mitochondrial swelling, cytochrome c release, and eventually mitochondrial loss (21, 32, 37) . Earlier studies have demonstrated that MT can protect against diabetic cardiomyopathy by suppressing mitochondrial oxidative stress (24) and restoring mitochondrial GSH levels (25) . It is not surprising that MT failed to restore the global GSH levels in response to GSH depletion in the current experimental setting. Last, the interrupted balance between the pro-and anti-apoptotic proteins also may contribute to the BSO-induced myocardial defect and MT-elicited cytoprotection.
Our results depict enhanced caspase-3 activity, upregulated pro-apoptotic Bax and p53, elevated phosphorylation of IB (reduced inhibition of NFB), and reduced anti-apoptotic Bcl-2 (but not ARC). Potentiation of the oxidative stress response by pro-apoptotic gene expression, formation of p53 fragments, release of cytochrome c, and caspase activation have been established to contribute to deteriorated cardiac function (38) . The fact that MT failed to prevent BSO-induced elevated p53 expression indicates a minimal role of p53 in MTelicited defense under the current experimental setting. Collectively, data from this study revealed a culprit role of GSH depletion in cardiac functional and ultrastructural abnormalities and, more importantly, the ability of MT to rescue the thiol-rich GSH depletion-induced detrimental myocardial consequences. These results have provided compelling evidence for an essential role of GSH and antioxidants in the maintenance of normal cardiac physiology and management of heart function in critical care medicine.
